Lyon Street Capital, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 77 filers reported holding RECRO PHARMA INC in Q3 2018. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lyon Street Capital, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2018$794,000
-67.6%
111,618
-77.2%
0.49%
-43.3%
Q2 2018$2,453,000
-78.3%
488,596
-52.4%
0.87%
-76.1%
Q1 2018$11,310,000
+236.4%
1,027,271
+182.6%
3.64%
+225.0%
Q4 2017$3,362,000363,4951.12%
Other shareholders
RECRO PHARMA INC shareholders Q3 2018
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders